Noile-Immune Biotech Inc. (4893.T)
JPY 163.0
(-1.81%)
JPY 163.0
(-1.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.9 Million JPY | 432.37% |
| 2022 | 3.92 Million JPY | -8.06% |
| 2021 | 4.27 Million JPY | -62.5% |
| 2020 | 11.38 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 16.58 Million JPY | -20.67% |
| 2024 Q2 | 11.58 Million JPY | -30.16% |
| 2023 Q3 | 22.58 Million JPY | 176.45% |
| 2023 FY | 20.9 Million JPY | 432.37% |
| 2023 Q1 | 3.61 Million JPY | -7.92% |
| 2023 Q2 | 8.17 Million JPY | 126.0% |
| 2023 Q4 | 20.9 Million JPY | -7.46% |
| 2022 Q4 | 3.92 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 96.94% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -16.576% |
| GNI Group Ltd. | 2.33 Billion JPY | 99.103% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 99.062% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 69.027% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 98.135% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 79.812% |
| AnGes, Inc. | 1.61 Billion JPY | 98.706% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 71.755% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 99.28% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 93.507% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -11259.239% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 85.086% |
| CanBas Co., Ltd. | 728 Thousand JPY | -2771.016% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 76.212% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 85.872% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 67.397% |
| Kidswell Bio Corporation | 875.65 Million JPY | 97.613% |
| PeptiDream Inc. | 2.4 Billion JPY | 99.131% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -291.258% |
| Ribomic Inc. | 2.27 Million JPY | -819.129% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -2090099900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | 41.942% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | 27.928% |
| CellSource Co., Ltd. | 305.92 Million JPY | 93.168% |
| FunPep Company Limited | 25.54 Million JPY | 18.167% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 94.259% |
| Stella Pharma Corporation | 1.11 Billion JPY | 98.128% |
| TMS Co., Ltd. | 50.02 Million JPY | 58.219% |
| Cuorips Inc. | 1.04 Million JPY | -1903.931% |
| K Pharma,Inc. | 10.79 Million JPY | -93.635% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.824% |
| ReproCELL Incorporated | 248.14 Million JPY | 91.577% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 95.361% |
| StemCell Institute Inc. | 42.26 Million JPY | 50.544% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 90.856% |
| CellSeed Inc. | 46.19 Million JPY | 54.751% |